Refine
Has Fulltext
- yes (11)
Is part of the Bibliography
- yes (11)
Document Type
- Journal article (11)
Language
- English (11)
Keywords
- 28 (1)
- NOTCH (1)
- QKD (1)
- TAVI (1)
- USP28 (1)
- aldosterone (1)
- antibiotic prescribing quality (1)
- antimicrobial stewardship (1)
- arterial thrombus formation (1)
- birth cohort (1)
Institute
- Medizinische Klinik und Poliklinik I (3)
- Institut für Experimentelle Biomedizin (2)
- Rudolf-Virchow-Zentrum (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Physikalische und Theoretische Chemie (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Klinik und Poliklinik für Strahlentherapie (1)
Sonstige beteiligte Institutionen
The transcription factor ∆Np63 is a master regulator of epithelial cell identity and essential for the survival of squamous cell carcinoma (SCC) of lung, head and neck, oesophagus, cervix and skin. Here, we report that the deubiquitylase USP28 stabilizes ∆Np63 and maintains elevated ∆NP63 levels in SCC by counteracting its proteasome‐mediated degradation. Impaired USP28 activity, either genetically or pharmacologically, abrogates the transcriptional identity and suppresses growth and survival of human SCC cells. CRISPR/Cas9‐engineered in vivo mouse models establish that endogenous USP28 is strictly required for both induction and maintenance of lung SCC. Our data strongly suggest that targeting ∆Np63 abundance via inhibition of USP28 is a promising strategy for the treatment of SCC tumours.